Takeda seeks DCGI permission for dengue vaccine trial The Drugs Controller General of India’s (DCGI) subject expert committee (SEC) took up Takeda’s proposal seeking permission for trials of its dengue tetravalent vaccine Qdenga, minutes of its 23 January meeting showed.
